Get Started
Multiple Sclerosis Curricula
Step 1
These independent CME/CE activities are supported by educational grants from Celgene Corporation, Novartis Pharmaceuticals Corporation, and
Sanofi Genzyme.



State of the                        Multiple Sclerosis
Science                              Innovations
  1. Course List
Chair
Anne H. Cross, MD
  • Professor of Neurology
  • Manny and Rosalyn Rosenthal - Dr. John Trotter MS Center Chair in Neuroimmunology
  • Division of Adult Neurology
  • Section Head, Neuroimmunology
  • Washington University School of Medicine
  • St. Louis, Missouri

  • Moderator
    Peggy Peck, Editor-in-Chief
  • Projects In Knowledge
  • Livingston, New Jersey

  • Faculty
    Patricia K. Coyle, MD
  • Professor and Vice Chair (Clinical Affairs)
  • Department of Neurology
  • Director, MS Comprehensive Care Center
  • Stony Brook University Medical Center
  • Stony Brook, New York

  • Patricia Melville, NP
  • Nurse Practitioner
  • Stony Brook University Neurosciences Institute
  • Outpatient Services
  • Stony Brook, New York

  • Amy Perrin Ross, MSN
  • Neuroscience Program Coordinator
  • Department of Neurosciences
  • Loyola University Chicago
  • Maywood, Illinois

  • Contributing Faculty
    James D. Bowen, MD
  • Medical Director, Multiple
  •   Sclerosis Center
  • Swedish Neuroscience
  •   Institute
  • Seattle, Washington

  • John R. Rinker, MD
  • Associate Professor of Neurology
  • Department of Neurology
  • University of Alabama at Birmingham
  • Birmingham, Alabama
  • Disclosure Information
    Anne H. Cross, MD   has conducted contracted research for EMD Serono, Roche, National MS Society, NIH, and The Conrad N. Hilton Foundation; and has received consulting fees from Biogen Idec, Genzyme (Sanofi-aventis), Novartis Pharmaceuticals Corporation, and Teva Neuroscience.and has ownership/interest in Affymetrix.

    Peggy Peck, Editor-in-Chief   has disclosed no relevant relationships.

    Patricia K. Coyle, MD   has received contracted research support from Actelion Pharmaceuticals, Genentech, a member of the Roche Group, NINDS, Novartis Pharmaceuticals Corporation, and Opexa Therapeutics, Inc; and has received consulting fees from Accordant Health Services (a CVS Caremark Company), Acorda Therapeutics, Bayer Healthcare Pharmaceuticals, Biogen Idec, Celgene, EMD Serono, Inc, Genentech, a member of the Roche Group, Genzyme Corporation, a Sanofi Company, Novartis Pharmaceuticals Corporation, and Teva Neuroscience.

    Patricia Melville, NP   has received consulting fees from Biogen, EMD Serono, Inc., Novartis Pharmaceuticals Corporation, and Sanofi-Genzyme; and has received honoraria from Biogen, EMD Serono, Inc., Novartis Pharmaceuticals Corporation, Sanofi-Genzyme, and Teva Neuroscience.

    Amy Perrin Ross, MSN   has received honoraria from Acorda Therapeutics, Biogen Idec, Novartis Pharmaceuticals Corporation, Pfizer Inc, Questcor Pharmaceuticals, and Teva Neuroscience; and has received consulting fees from Acorda Therapeutics, Allergen, Bayer Healthcare Pharmaceuticals, EMD Serono, Genzyme Corporation, Novartis Pharmaceuticals Corporation, Pfizer Inc, Questcor Pharmaceuticals, Sanofi Aventis, and Teva Neuroscience.

    James D. Bowen, MD   received financial support for research activities from Acorda Therapeutics, Alexion, Allergan, Biogen, EMD Serono Inc, Genzyme, a Sanofi Company, Genentech, GlaxoSmithKline, Novartis, Opexa, Osmotica, Roche, sanofi-aventis U.S. LLC, and Xenoport; has received consulting fees from Acorda Therapeutics, Biogen, EMD Serono Inc, Genzyme, a Sanofi Company, Genentech, Novartis, and Teva Neuroscience; and has received honoraria from Acorda Therapeutics, Biogen, EMD Serono Inc, Genentech, Novartis, Pfizer Inc, and Teva Neuroscience.

    John R. Rinker, MD   has conducted contract research for Biogen Idec.